ELEDON PHARMACEUTICALS INC (ELDN) Forecast, Price Target & Analyst Ratings

NASDAQ:ELDN • US28617K1016

Current stock price

3.085 USD
+0 (+0.16%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELEDON PHARMACEUTICALS INC (ELDN).

Forecast Snapshot

Consensus Price Target

Price Target
$8.16
+ 164.51% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.23
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.16
Upside
+ 164.51%
From current price of $3.09 to mean target of $8.16, Based on 13 analyst forecasts
Low
$4.04
Median
$8.67
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for ELDN. The average price target is 8.16 USD. This implies a price increase of 164.51% is expected in the next year compared to the current price of 3.085.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ELDN Current Analyst RatingELDN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ELDN Historical Analyst RatingsELDN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
ELDN was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELDN.
In the previous month the buy percentage consensus was at a similar level.
ELDN was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-18GuggenheimMaintains Buy -> Buy
2025-09-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-25Craig-HallumInitiate Buy
2024-11-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-07HC Wainwright & Co.Maintains Buy -> Buy
2024-03-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-24HC Wainwright & Co.Maintains Buy -> Buy
2023-09-27Noble Capital MarketsInitiate Outperform
2023-08-22Cantor FitzgeraldReiterate Overweight -> Overweight
2023-05-26HC Wainwright & Co.Reiterate Buy -> Buy
2022-06-01SVB LeerinkMaintains Outperform
2021-11-24HC Wainwright & Co.Maintains Buy
2021-04-27SVB LeerinkMaintains Outperform
2021-03-23Cantor FitzgeraldInitiate Overweight
2021-02-08SVB LeerinkInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.23
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-183.05%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
3.48%
EPS (3 Months)
3.48%

Next Earnings Summary

ELDN is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ELDN revenue by date.ELDN revenue by date.
N/AN/AN/AN/AN/A
275.19%		N/A
164.37%		N/A
80.26%		N/A
63.31%
EBITDA
YoY % growth
ELDN ebitda by date.ELDN ebitda by date.
-45.15M-37.95M
15.95%		-13.1M
65.48%		-14.05M
-7.25%		-14.17M
-0.85%		-16.18M
-14.18%		-36.87M
-127.87%		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ELDN ebit by date.ELDN ebit by date.
-45.26M-38.12M
15.78%		-13.12M
65.58%		-14.06M
-7.16%		-14.18M
-0.85%		-16.19M
-14.17%		-36.87M
-127.73%		-39.78M
-7.89%		-43M
-8.09%		-70.577M
-64.13%		-83.251M
-17.96%		N/A
-17.58%		N/A
-14.87%		N/A
-0.14%		N/A
13.17%		N/A
50.97%		N/A
141.49%		N/A
474.36%		N/A
120.54%
Operating Margin
ELDN operating margin by date.ELDN operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ELDN eps by date.ELDN eps by date.
-325.62-273.78
15.92%		N/A
85.58%		-28.08
28.86%		-22.86
18.59%		-13.21
42.22%		-2.32
82.43%		-2.76
-18.97%		-1.79
35.14%		-1.05
41.34%		-0.52
50.48%		N/A
-73.60%		N/A
0.94%		N/A
-15.21%		N/A
15.84%		N/A
-1.18%		N/A
25.58%		N/A
21.88%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.23
-183.05%		-0.21
-64.77%		-0.23
-8.80%		-0.23
-128.48%		-0.21
5.41%		-0.22
-4.76%		-0.23
-2.68%		-0.24
-7.14%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-23.332M
-29.88%		-24.689M
0.18%		-25.249M
-32.40%		-25.858M
-20.36%		-24.48M
-4.92%		-25.755M
-4.32%		-27.03M
-7.05%		-28.305M
-9.46%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ELDN Yearly Revenue VS EstimatesELDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M
ELDN Yearly EPS VS EstimatesELDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -100 -200 -300

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-25.60%
EPS Next 5 Year
-11.02%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELEDON PHARMACEUTICALS INC / ELDN Forecast FAQ

Can you provide the average price target for ELEDON PHARMACEUTICALS INC stock?

13 analysts have analysed ELDN and the average price target is 8.16 USD. This implies a price increase of 164.51% is expected in the next year compared to the current price of 3.085.

What is the next earnings date for ELDN stock?

ELEDON PHARMACEUTICALS INC (ELDN) will report earnings on 2026-05-12.

Can you provide the consensus estimates for ELEDON PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of ELEDON PHARMACEUTICALS INC (ELDN) is -0.23 USD and the consensus revenue estimate is 0 USD.